P C Comp

2.3k total citations · 1 hit paper
24 papers, 1.8k citations indexed

About

P C Comp is a scholar working on Hematology, Internal Medicine and Genetics. According to data from OpenAlex, P C Comp has authored 24 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Internal Medicine and 5 papers in Genetics. Recurrent topics in P C Comp's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Atrial Fibrillation Management and Outcomes (4 papers). P C Comp is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Atrial Fibrillation Management and Outcomes (4 papers). P C Comp collaborates with scholars based in United States and Japan. P C Comp's co-authors include Charles T. Esmon, M. Robert Cooper, Randal R. Nixon, Armando D’Angelo, Paul W. Kincade, Takafumi Yokota, Hideya Igarashi, Silvana Vigano’D’Angelo, Sergio D’Angelo and N L Esmon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

P C Comp

24 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Familial protein S deficiency is associated with recurrent thrombosis.

1984 488 citations P C Comp, Randal R. Nixon et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by P C Comp

Since Specialization

Citations

This map shows the geographic impact of P C Comp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P C Comp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P C Comp more than expected).

Fields of papers citing papers by P C Comp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P C Comp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P C Comp. The network helps show where P C Comp may publish in the future.

Co-authorship network of co-authors of P C Comp

This figure shows the co-authorship network connecting the top 25 collaborators of P C Comp. A scholar is included among the top collaborators of P C Comp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P C Comp. P C Comp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins 2002 ·Journal of Clinical Investigation ·Takafumi Yokota, C.S. Reddy Meka, Kay L. Medina, Hideya Igarashi, P C Comp, Masahiko Takahashi, Makoto Nishida, Kenji Oritani, Jun-ichiro Miyagawa, Tohru Funahashi, Yoshiaki Tomiyama, Yūji Matsuzawa, Paul W. Kincade	123
2	Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins 2002 ·Journal of Clinical Investigation ·Takafumi Yokota, C.S. Reddy Meka, Kay L. Medina, Hideya Igarashi, P C Comp, Masahiko Takahashi, Makoto Nishida, Kenji Oritani, Jun‐ichiro Miyagawa, Tohru Funahashi, Yoshiaki Tomiyama, Yūji Matsuzawa, Paul W. Kincade	109
3	Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins 2002 ·Journal of Clinical Investigation ·Takafumi Yokota, C.S. Reddy Meka, Kay L. Medina, Hideya Igarashi, P C Comp, Masahiko Takahashi, Makoto Nishida, Kenji Oritani, Jun‐ichiro Miyagawa, Tohru Funahashi, Yoshiaki Tomiyama, Yūji Matsuzawa, Paul W. Kincade	7
4	Relatively Normal Human Lymphopoiesis but Rapid Turnover of Newly Formed B Cells in Transplanted Nonobese Diabetic/SCID Mice 2001 ·The Journal of Immunology ·Maria Isabel D. Rossi, Kay L. Medina, Karla P. Garrett, Grant R. Kolar, P C Comp, Leonard D. Shultz, J D Capra, Patrick C. Wilson, (unknown), Paul W. Kincade	33
5	Age and stage dependency of estrogen receptor expression by lymphocyte precursors 2001 ·Proceedings of the National Academy of Sciences ·Hideya Igarashi, Taku Kouro, Takafumi Yokota, P C Comp, Paul W. Kincade	127
6	Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis. 2000 ·PubMed ·C W Carson, P C Comp, Alireza R. Rezaie, N L Esmon, Charles T. Esmon	20
7	A Comparison of Danaparoid and Warfarin for Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement 1998 ·Orthopedics ·P C Comp, (unknown), JOHN W. MCCUTCHEN, Vasilios A. Skoutakis, Arthur A. Trowbridge, (unknown)	19
8	A double-blind multicenter clinical trial comparing long term enoxaparin and placebo treatments in the prevention of venous thromboembolic disease after hip and knee replacement surgery 1998 ·The Journal of Arthroplasty ·Theodore E. Spiro, P C Comp, Richard J. Friedman, G.A. Gardiner, Thomas L. Whitsett, Glenn C. Landon, Maurice Jové, Gerhard J. Johnson	4
9	Thrombophilic mechanisms of OCs. 1997 ·PubMed ·P C Comp	6
10	On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. 1995 ·Journal of Clinical Investigation ·M D Smirnov, (unknown), P C Comp, N L Esmon, CT Esmon	113
11	Some clotting factors in plasma during danazol therapy: free and total protein S, but not C4b-binding protein, are elevated by danazol therapy. 1992 ·PubMed ·(unknown), (unknown), Howard J. Schwartz, P C Comp, John J. Haluschak, (unknown)	8
12	Overview of the Hypercoagulable States 1990 ·Seminars in Thrombosis and Hemostasis ·P C Comp	6
13	Laboratory Evaluation of Protein S Status 1990 ·Seminars in Thrombosis and Hemostasis ·P C Comp	42
14	Warfarin-Induced Skin Necrosis 1990 ·Seminars in Thrombosis and Hemostasis ·P C Comp, (unknown), (unknown)	40
15	Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. 1988 ·Journal of Clinical Investigation ·Armando D’Angelo, Silvana Vigano’D’Angelo, Charles T. Esmon, P C Comp	160
16	Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis. 1987 ·Arteriosclerosis An Official Journal of the American Heart Association Inc ·BS Coller, J Owen, Jolyon Jesty, Deborah Horowitz, Milton J. Reitman, J F Spear, (unknown), P C Comp	90
17	Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. 1986 ·Journal of Clinical Investigation ·Sergio D’Angelo, P C Comp, Charles T. Esmon, Armando D’Angelo	139
18	Familial protein S deficiency is associated with recurrent thrombosis. breakdown → 1984 ·Journal of Clinical Investigation ·P C Comp, Randal R. Nixon, M. Robert Cooper, Charles T. Esmon	488
19	A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity. 1981 ·PubMed ·P C Comp, (unknown), (unknown), Robert Radcliffe	25
20	Generation of fibrinolytic activity by infusion of activated protein C into dogs. 1981 ·Journal of Clinical Investigation ·P C Comp, Charles T. Esmon	239

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact